NBY
AMEX · Pharmaceuticals
Novabay Pharmaceuticals Inc
$1.45
-0.05 (-3.33%)
Open$1.64
Previous Close$1.50
Day High$1.65
Day Low$1.42
52W High$99.75
52W Low$1.11
Volume—
Avg Volume929.1K
Market Cap31.35M
P/E Ratio—
EPS$-6.62
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+1,870.3% upside
Current
$1.45
$1.45
Target
$28.57
$28.57
$17.04
$28.57 avg
$34.41
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 73.41M | 69.83M | 19.57M |
| Net Income | -54,209,349 | -46,412,113 | 4.44M |
| Profit Margin | -73.9% | -70.2% | 22.7% |
| EBITDA | -53,676,661 | -48,509,159 | 7.02M |
| Free Cash Flow | — | — | 4.00M |
| Rev Growth | +5.1% | +5.1% | -0.9% |
| Debt/Equity | 0.34 | 0.34 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |